Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3596409
Max Phase: Preclinical
Molecular Formula: C29H30O8
Molecular Weight: 506.55
Molecule Type: Small molecule
Associated Items:
ID: ALA3596409
Max Phase: Preclinical
Molecular Formula: C29H30O8
Molecular Weight: 506.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OC[C@H]1O[C@H](OC(COc2ccc3ccccc3c2)COc2ccc3ccccc3c2)[C@@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C29H30O8/c30-15-25-26(31)27(32)28(33)29(37-25)36-24(16-34-22-11-9-18-5-1-3-7-20(18)13-22)17-35-23-12-10-19-6-2-4-8-21(19)14-23/h1-14,24-33H,15-17H2/t25-,26-,27+,28+,29+/m1/s1
Standard InChI Key: RCZAKMGKDSJMNU-PNHLWVRCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 506.55 | Molecular Weight (Monoisotopic): 506.1941 | AlogP: 2.64 | #Rotatable Bonds: 9 |
Polar Surface Area: 117.84 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.21 | CX Basic pKa: | CX LogP: 3.04 | CX LogD: 3.04 |
Aromatic Rings: 4 | Heavy Atoms: 37 | QED Weighted: 0.27 | Np Likeness Score: 0.75 |
1. Tomasic T, Rabbani S, Gobec M, Rascan IM, Podlipnik C, Ernst B, Anderluh M. (2014) Branched -d-mannopyranosides: a new class of potent FimH antagonists, 5 (8): [10.1039/C4MD00093E] |
Source(1):